The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lauritsen, 2014, The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone, Hum Reprod, 29, 791, 10.1093/humrep/det469
Stein, 1935, Amenorrhea associated with bilateral polycystic ovaries, Am J Obstet Gynecol, 29, 181, 10.1016/S0002-9378(15)30642-6
Azziz, 2016, Stein and Leventhal: 80 years on, Am J Obstet Gynecol, 214, 247.e1, 10.1016/j.ajog.2015.12.013
Goldzieher, 1962, The polycystic ovary. I. Clinical and histologic features, J Clin Endocrinol Metab, 22, 325, 10.1210/jcem-22-3-325
McArthur, 1958, The urinary excretion of interstitial-cell and follicle-stimulating hormone activity by women with diseases of the reproductive system, J Clin Endocrinol Metab, 18, 1202, 10.1210/jcem-18-11-1202
Yen, 1970, Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease, J Clin Endocrinol Metab, 30, 435, 10.1210/jcem-30-4-435
Rosenfield, 1972, Adrenal and ovarian contributions to the elevated free plasma androgen levels in hirsute women, J Clin Endocrinol Metab, 34, 92, 10.1210/jcem-34-1-92
Futterweit, 1986, Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals, J Clin Endocrinol Metab, 62, 16, 10.1210/jcem-62-1-16
Franks, 1989, Polycystic ovary syndrome: a changing perspective, Clin Endocrinol, 31, 87, 10.1111/j.1365-2265.1989.tb00457.x
Barbieri, 1983, Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features, Am J Obstet Gynecol, 147, 90, 10.1016/0002-9378(83)90091-1
Chang, 1983, Insulin resistance in nonobese patients with polycystic ovary disease, J Clin Endocrinol Metab, 57, 356, 10.1210/jcem-57-2-356
Dunaif, 1989, Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome, Diabetes, 38, 1165, 10.2337/diab.38.9.1165
Barbieri, 1986, Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism, J Clin Endocrinol Metab, 904, 10.1210/jcem-62-5-904
Hernandez, 1988, Insulin as a regulator of androgen biosynthesis by cultured rat ovarian cells: cellular mechanism (s) underlying physiological and pharmacological hormonal actions, Endocrinology, 122, 2034, 10.1210/endo-122-5-2034
Cara, 1988, Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian theca-interstitial cells, Endocrinology, 123, 733, 10.1210/endo-123-2-733
Barnes, 1989, Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome, N Engl J Med, 320, 559, 10.1056/NEJM198903023200904
Rosenfield, 1990, Dysregulation of cytochrome P450c 17α as the cause of polycystic ovary syndrome, Fertil Steril, 53, 785, 10.1016/S0015-0282(16)53510-9
Ehrmann, 1992, Detection of functional ovarian hyperandrogenism in women with androgen excess, N Engl J Med, 327, 157, 10.1056/NEJM199207163270304
Rosenfield, 1992, Ovarian steroidogenic abnormalities in polycystic ovary syndrome: evidence for abnormal coordinate regulation of androgen and estrogen secretion, Polycystic Ovary Syndrome, 83
Zawadzki, 1992, Diagnostic criteria for polycystic ovary syndrome: towards a rational approach, Polycystic Ovary Syndrome, 377
Ehrmann, 1995, Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion, Endocr Rev, 16, 322, 10.1210/er.16.3.322
Nelson, 1999, Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries, Mol Endocrinol, 13, 946, 10.1210/mend.13.6.0311
Ciaraldi, 2009, Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance, J Clin Endocrinol Metab, 94, 157, 10.1210/jc.2008-1492
Wu, 2014, Obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell, Diabetes, 63, 1270, 10.2337/db13-1514
Balen, 2003, Ultrasound assessment of the polycystic ovary: international consensus definitions, Hum Reprod Update, 9, 505, 10.1093/humupd/dmg044
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertil Steril, 81, 19, 10.1016/j.fertnstert.2003.10.004
Azziz, 2009, The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report, Fertil Steril, 91, 456, 10.1016/j.fertnstert.2008.06.035
Johnson T , KaplanL, OuyangP, RizzaR. National Institutes of Health evidence-based methodology workshop on polycystic ovary syndrome (PCOS). NIH EbMW Report. 2013. Available from https://prevention.nih.gov/programs-events/pathways-to-prevention/previous-workshops/pcos/workshop-resources. Bethesda, MD: National Institutes of Health; 1–14.
Rosenfield, 2015, The polycystic ovary morphology-polycystic ovary syndrome spectrum, J Pediatr Adolesc Gynecol, 28, 412, 10.1016/j.jpag.2014.07.016
Adams, 2004, Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome, J Clin Endocrinol Metab, 89, 4343, 10.1210/jc.2003-031600
Barber, 2007, Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome, Clin Endocrinol, 66, 513, 10.1111/j.1365-2265.2007.02764.x
Guastella, 2010, Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes, Fertil Steril, 94, 2197, 10.1016/j.fertnstert.2010.02.014
Clark, 2014, Prevalence of polycystic ovary syndrome phenotypes using updated criteria for polycystic ovarian morphology: an assessment of over 100 consecutive women self-reporting features of polycystic ovary syndrome, Reprod Sci, 21, 1034, 10.1177/1933719114522525
Ladron de Guevara, 2014, Metabolic profile of the different phenotypes of polycystic ovary syndrome in two Latin American populations, Fertil Steril, 101, 10.1016/j.fertnstert.2014.02.020
Christ, 2015, Ultrasound features of polycystic ovaries relate to degree of reproductive and metabolic disturbance in polycystic ovary syndrome, Fertil Steril, 103, 787, 10.1016/j.fertnstert.2014.12.094
Romualdi, 2015, The role of anti-Müllerian hormone in the characterization of the different polycystic ovary syndrome phenotypes, Reprod Sci, 23, 655, 10.1177/1933719115611751
Martin, 2008, Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society Clinical Practice Guideline, J Clin Endocrin Metab, 93, 1105, 10.1210/jc.2007-2437
Rosenfield, 2012, Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries, Fertil Steril, 98, 242, 10.1016/j.fertnstert.2012.03.059
Lauritsen, 2015, Revised criteria for PCOS in WHO Group II anovulatory infertility - a revival of hypothalamic amenorrhoea?, Clin Endocrinol, 82, 584, 10.1111/cen.12621
Rosenfield, 2005, Clinical practice. Hirsutism [comment appears in N Engl J Med. 2006;354(14):1533–1535; author reply 1533–1535], N Engl J Med, 353, 2578, 10.1056/NEJMcp033496
Rosenfield, 2013, Clinical review: adolescent anovulation: maturational mechanisms and implications, J Clin Endocrinol Metab, 98, 3572, 10.1210/jc.2013-1770
Rosner, 2010, Toward excellence in testosterone testing: a consensus statement, J Clin Endocrinol Metab, 95, 4542, 10.1210/jc.2010-1314
Auchus, 2014, Steroid assays and endocrinology: best practices for basic scientists, Endocrinology, 155, 2049, 10.1210/en.2014-7534
Rosner, 2007, Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement, J Clin Endocrinol Metab, 92, 405, 10.1210/jc.2006-1864
Legro, 2010, Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism, J Clin Endocrinol Metab, 95, 5305, 10.1210/jc.2010-1123
Rosenfield, 2011, Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test, Hum Reprod, 26, 3138, 10.1093/humrep/der291
Salameh, 2014, Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria, Fertil Steril, 101, 1135, 10.1016/j.fertnstert.2013.12.056
Dewailly, 2014, Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society, Hum Reprod Update, 20, 334, 10.1093/humupd/dmt061
Rosenfield, 2015, The diagnosis of polycystic ovary syndrome in adolescents, Pediatrics, 136, 1154, 10.1542/peds.2015-1430
Witchel, 2015, The diagnosis of polycystic ovary syndrome during adolescence, Horm Res Paediatr, 83, 376, 10.1159/000375530
Littlejohn, 2007, Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome, J Pediatr Endocrinol Metab, 20, 41, 10.1515/JPEM.2007.20.1.41
Rosenfield, 2015, Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood, J Clin Endocrinol Metab, 100, 1537, 10.1210/jc.2014-4290
Winters, 2000, Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome, Fertil Steril, 73, 724, 10.1016/S0015-0282(99)00641-X
Elting, 2001, Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome, Clin Endocrinol, 55, 767, 10.1046/j.1365-2265.2001.01412.x
Burger, 2007, A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project, Hum Reprod Update, 13, 559, 10.1093/humupd/dmm020
Fauser, 2012, Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group, Fertil Steril, 97, 28, 10.1016/j.fertnstert.2011.09.024
Horton, 1966, Androstenedione and testosterone in ovarian venous and peripheral plasma during ovariectomy for breast cancer, J Clin Endocrinol Metab, 26, 1267, 10.1210/jcem-26-11-1267
Horton, 1966, Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone, J Clin Invest, 45, 301, 10.1172/JCI105344
Kirschner, 1972, Androgen production and metabolism in normal and virilized women, Metabolism, 21, 667, 10.1016/0026-0495(72)90090-X
Walters, 2007, Female mice haploinsufficient for an inactivated androgen receptor (AR) exhibit age-dependent defects that resemble the AR null phenotype of dysfunctional late follicle development, ovulation, and fertility, Endocrinology, 148, 3674, 10.1210/en.2007-0248
Miller, 2011, The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders, Endocr Rev, 32, 81, 10.1210/er.2010-0013
Kiriakidou, 1996, Expression of steroidogenic acute regulatory protein (StAR) in the human ovary, J Clin Endocrinol Metab, 81, 4122
Miller, 2015, The post-translational regulation of 17,20 lyase activity, Mol Cell Endocrinol, 408, 99, 10.1016/j.mce.2014.09.010
Anakwe, 1987, Noncoordinate regulation of de novo synthesis of cytochrome P-450 cholesterol side-chain cleavage and cytochrome P-450 17α-hydroxylase/C17–20 lyase in mouse Leydig cell cultures: relation to steroid production, Mol Endocrinol, 1, 595, 10.1210/mend-1-9-595
Magoffin, 1989, Evidence that luteinizing hormone-stimulated differentiation of purified ovarian thecal-interstitial cells is mediated by both type I and type II adenosine 3′,5′-monophosphate-dependent protein kinases, Endocrinology, 125, 1464, 10.1210/endo-125-3-1464
John, 1986, Transcriptional regulation of steroid hydroxylase genes by corticotropin, Proc Natl Acad Sci USA, 83, 4715, 10.1073/pnas.83.13.4715
Di Blasio, 1987, Hormonal regulation of messenger ribonucleic acids for P450scc (cholesterol side-chain cleavage enzyme) and P450c17 (17 α-hydroxylase/17,20 lyase) in cultured human fetal adrenal cells, J Clin Endocrinol Metab, 65, 170, 10.1210/jcem-65-1-170
Kase, 1961, In vitro production of testosterone and androst-4-ene-3,17-dione in a human ovarian homogenate, Acta Endocrinol (Copenh), 37, 19, 10.1530/acta.0.0370019
Axelrod, 1962, The polycystic ovary. III. Steroid biosynthesis in normal and polycystic ovarian tissue, J Clin Endocrinol, 22, 431, 10.1210/jcem-22-4-431
Dorfman, 1963, Androgen biosynthesis and related studies, Rec Prog Horm Res, 19, 251
Nelson, 2001, The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome, J Clin Endocrinol Metab, 86, 5925, 10.1210/jcem.86.12.8088
Longcope, 1988, Androgen and estrogen dynamics in pre- and postmenopausal women: a comparison between smokers and nonsmokers, J Clin Endocrinol Metab, 67, 379, 10.1210/jcem-67-2-379
Gibb, 1980, Substrate specificity of the placental microsomal aromatase, Steroids, 36, 507, 10.1016/0039-128X(80)90074-4
Simpson, 1994, Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis, Endocr Rev, 15, 342
McNatty, 1979, Metabolism of androstenedione by human ovarian tissues in vitro with particular reference to reductase and aromatase activity, Steroids, 34, 429, 10.1016/0039-128X(79)90104-1
Jakimiuk, 1999, 5α-reductase activity in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 84, 2414
Prizant, 2014, Androgen actions in the ovary: balance is key, J Endocrinol, 222, R141, 10.1530/JOE-14-0296
Daniels, 1997, Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogenic anovulation, J Clin Endocrinol Metab, 82, 4179
Bogumil, 1972, Mathematical studies of the human menstrual cycle. I. Formation of a mathematical model, J Clin Endocrinol Metab, 35, 126, 10.1210/jcem-35-1-126
Welt, 2001, Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development, J Clin Endocrinol Metab, 86, 2531
Rosenfield, 2010, Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity, Brain Res, 1364, 186, 10.1016/j.brainres.2010.08.088
Foecking, 2005, Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator, Biol Reprod, 72, 1475, 10.1095/biolreprod.105.039800
Aono, 1978, Absence of positive feedback effect of oestrogen on LH release in patients with testicular feminization syndrome, Acta Endocrinol (Copenh), 87, 259, 10.1530/acta.0.0870259
Nicoletti, 1981, Effect of estrogens and progesterone on gonadotropin and prolactin release in a patient with androgen insensitivity, Obstet Gynecol, 58, 527
Wu, 2014, Conditional knockout of the androgen receptor in gonadotropes reveals crucial roles for androgen in gonadotropin synthesis and surge in female mice, Mol Endocrinol, 28, 1670, 10.1210/me.2014-1154
Nahum, 1995, Metabolic regulation of androgen production by human thecal cells in vitro, Hum Reprod, 10, 75, 10.1093/humrep/10.1.75
Willis, 1996, Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries, J Clin Endocrinol Metab, 81, 302
Chang, 2013, Disordered follicle development, Mol Cell Endocrinol, 373, 51, 10.1016/j.mce.2012.07.011
Cara, 1990, Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells, J Clin Invest, 86, 560, 10.1172/JCI114745
Bhaskaran, 2005, The post-endocytotic fate of the gonadotropin receptors is an important determinant of the desensitization of gonadotropin responses, J Mol Endocrinol, 34, 447, 10.1677/jme.1.01745
Menon, 2014, Eukaryotic initiation factor 5A plays an essential role in luteinizing hormone receptor regulation, Mol Endocrinol, 28, 1796, 10.1210/me.2014-1132
Wolf-Ringwall, 2014, Luteinizing hormone receptors are confined in mesoscale plasma membrane microdomains throughout recovery from receptor desensitization, Cell Biochem Biophys, 68, 561, 10.1007/s12013-013-9738-x
Hirshfeld-Cytron, 2009, Characterization of functionally typical and atypical types of polycystic ovary syndrome, J Clin Endocrinol Metab, 94, 1587, 10.1210/jc.2008-2248
Levrant, 1997, A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism, Hum Reprod, 12, 1416, 10.1093/humrep/12.7.1416
McCartney, 2004, Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome, Am J Physiol Endocrinol Metab, 286, E902, 10.1152/ajpendo.00415.2003
Couse, 1999, Estrogen receptor null mice: what have we learned and where will they lead us? [erratum appears in Endocr Rev. 1999;20(4):459], Endocr Rev, 20, 358, 10.1210/edrv.20.3.0370
Taniguchi, 2007, Estrogen receptor-α mediates an intraovarian negative feedback loop on thecal cell steroidogenesis via modulation of Cyp17a1 (cytochrome P450, steroid 17α-hydroxylase/17,20 lyase) expression, FASEB, 21, 586, 10.1096/fj.06-6681com
Duda, 2014, The impact of antiandrogen 2-hydroxyflutamide on the expression of steroidogenic enzymes in cultured porcine ovarian follicles, Mol Biol Rep, 41, 4213, 10.1007/s11033-014-3291-6
McAllister, 1994, The effects of growth factors and phorbol esters on steroid biosynthesis in isolated human theca interna and granulosa-lutein cells in long term culture, J Clin Endocrinol Metab, 79, 106
Barnes, 2002, The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries, Hum Reprod, 17, 88, 10.1093/humrep/17.1.88
Barnes, 2000, Effect of follicle-stimulating hormone on ovarian androgen production in a woman with isolated follicle-stimulating hormone deficiency, N Engl J Med, 343, 1197, 10.1056/NEJM200010193431614
Munir, 2004, Insulin augmentation of 17α-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells, Endocrinology, 145, 175, 10.1210/en.2003-0329
Magoffin, 1994, Insulin-like growth factor-I regulation of luteinizing hormone (LH) receptor messenger ribonucleic acid expression and LH-stimulated signal transduction in rat ovarian theca-interstitial cells, Biol Reprod, 51, 766, 10.1095/biolreprod51.4.766
Du, 2009, KLF15 is a transcriptional regulator of the human 17β-hydroxysteroid dehydrogenase type 5 gene. A potential link between regulation of testosterone production and fat stores in women, J Clin Endocrinol Metab, 94, 2594, 10.1210/jc.2009-0139
McAllister, 2014, Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype, Proc Natl Acad Sci USA, 111, E1519, 10.1073/pnas.1400574111
Andersen, 2008, Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-Müllerian hormone and inhibin-B, Fertil Steril, 89, 1760, 10.1016/j.fertnstert.2007.05.003
Hoang, 2013, Paracrine regulation of theca androgen production by granulosa cells in the ovary, Fertil Steril, 100, 561, 10.1016/j.fertnstert.2013.04.016
Kottler, 2010, A new FSHβ mutation in a 29-year-old woman with primary amenorrhea and isolated FSH deficiency: functional characterization and ovarian response to human recombinant FSH, Eur J Endocrinol, 162, 633, 10.1530/EJE-09-0648
Dooley, 2000, Bone morphogenetic protein inhibits ovarian androgen production, J Clin Endocrinol Metab, 85, 3331, 10.1210/jcem.85.9.6835
Young, 2010, Theca: the forgotten cell of the ovarian follicle, Reproduction, 140, 489, 10.1530/REP-10-0094
Dumesic, 2013, Ontogeny of the ovary in polycystic ovary syndrome, Fertil Steril, 100, 23, 10.1016/j.fertnstert.2013.02.011
Raja-Khan, 2014, The role of TGF-β in polycystic ovary syndrome, Reprod Sci, 21, 20, 10.1177/1933719113485294
Glister, 2013, Functional link between bone morphogenetic proteins and insulin-like peptide 3 signaling in modulating ovarian androgen production, Proc Natl Acad Sci USA, 110, E1426, 10.1073/pnas.1222216110
Hatzirodos, 2011, Linkage of regulators of TGF-β activity in the fetal ovary to polycystic ovary syndrome, FASEB, 25, 2256, 10.1096/fj.11-181099
González, 2015, Nutrient-induced inflammation in polycystic ovary syndrome: role in the development of metabolic aberration and ovarian dysfunction, Semin Reprod Med, 33, 276, 10.1055/s-0035-1554918
Jiang, 2015, MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome, J Clin Endocrinol Metab, 100, E729, 10.1210/jc.2014-3827
Heider, 2001, Increase in nerve fibers and loss of mast cells in polycystic and postmenopausal ovaries, Fertil Steril, 75, 1141, 10.1016/S0015-0282(01)01805-2
Dissen, 2009, Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans, Endocrinology, 150, 2906, 10.1210/en.2008-1575
Lansdown, 2012, The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?, Clin Endocrinol, 77, 791, 10.1111/cen.12003
Wilson, 2014, Excess of nerve growth factor in the ovary causes a polycystic ovary-like syndrome in mice, which closely resembles both reproductive and metabolic aspects of the human syndrome, Endocrinology, 155, 4494, 10.1210/en.2014-1368
Fauser, 1997, Manipulation of human ovarian function: physiological concepts and clinical consequences, Endocr Rev, 18, 71
Hsueh, 2015, Intraovarian control of early folliculogenesis, Endocr Rev, 36, 1, 10.1210/er.2014-1020
Teng, 2015, S100A8, an oocyte-specific chemokine, directs the migration of ovarian somatic cells during mouse primordial follicle assembly, J Cell Physiol, 230, 2998, 10.1002/jcp.25032
Chakraborty, 2015, Bone morphogenetic protein 2 promotes primordial follicle formation in the ovary, Sci Rep, 5, 12664, 10.1038/srep12664
Jiang, 2016, LKB1 acts as a critical gatekeeper of ovarian primordial follicle pool, Oncotarget, 7, 5738, 10.18632/oncotarget.6792
Castrillon, 2003, Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a, Science, 301, 215, 10.1126/science.1086336
Schmidt, 2004, The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance, Development, 131, 933, 10.1242/dev.00969
Childs, 2010, BMP signaling in the human fetal ovary is developmentally regulated and promotes primordial germ cell apoptosis, Stem Cells, 28, 1368, 10.1002/stem.440
Glister, 2010, Changes in expression of bone morphogenetic proteins (BMPs), their receptors and inhibin co-receptor betaglycan during bovine antral follicle development: inhibin can antagonize the suppressive effect of BMPs on thecal androgen production, Reproduction, 140, 699, 10.1530/REP-10-0216
Durlinger, 1999, Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary, Endocrinology, 140, 5789, 10.1210/endo.140.12.7204
Couse, 1999, Postnatal sex reversal of the ovaries in mice lacking estrogen receptors α and β, Science, 286, 2328, 10.1126/science.286.5448.2328
Kezele, 2002, Insulin but not insulin-like growth factor-1 promotes the primordial to primary follicle transition, Mol Cell Endocrinol, 192, 37, 10.1016/S0303-7207(02)00114-4
Vendola, 1998, Androgens stimulate early stages of follicular growth in the primate ovary, J Clin Invest, 101, 2622, 10.1172/JCI2081
Persani, 2014, The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders, Hum Reprod Update, 20, 869, 10.1093/humupd/dmu036
Gougeon, 1996, Regulation of ovarian follicular development in primates: facts and hypotheses, Endocrin Rev, 17, 121, 10.1210/edrv-17-2-121
Rani, 1981, Follicle-stimulating hormone induction of luteinizing hormone receptor in cultured rat granulosa cells: an examination of the need for steroids in the induction process, Endocrinology, 108, 1379, 10.1210/endo-108-4-1379
Welt, 2005, Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis, J Clin Endocrinol Metab, 90, 5582, 10.1210/jc.2005-0695
Jakimiuk, 1998, Aromatase mRNA expression in individual follicles from polycystic ovaries, Mol Hum Reprod, 4, 1, 10.1093/molehr/4.1.1
Dewailly, 2014, 2014 The physiology and clinical utility of anti-Mullerian hormone in women [erratum appears in Hum Reprod Update. 2014;2020(2015):2804], Hum Reprod Update, 20, 370, 10.1093/humupd/dmt062
Jonard, 2004, The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest, Hum Reprod Update, 10, 107, 10.1093/humupd/dmh010
Eldar-Geva, 2005, Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism, Hum Reprod, 20, 1814, 10.1093/humrep/deh873
Lebbe, 2013, Involvement of androgens in ovarian health and disease, Mol Hum Reprod, 19, 828, 10.1093/molehr/gat065
Weil, 1998, Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations, J Clin Endocrinol Metab, 83, 2479, 10.1210/jcem.83.7.4917
Weil, 1999, Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development, J Clin Endocrinol Metab, 84, 2951, 10.1210/jcem.84.8.5929
Rice, 2007, Stage-specific expression of androgen receptor, follicle-stimulating hormone receptor, and anti-Müllerian hormone type II receptor in single, isolated, human preantral follicles: relevance to polycystic ovaries, J Clin Endocrinol Metab, 92, 1034, 10.1210/jc.2006-1697
Sen, 2010, Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function, Mol Endocrinol, 24, 1393, 10.1210/me.2010-0006
Walters, 2012, Targeted loss of androgen receptor signaling in murine granulosa cells of preantral and antral follicles causes female subfertility, Biol Reprod, 87, 151, 10.1095/biolreprod.112.102012
Hillier, 2001, Gonadotropic control of ovarian follicular growth and development, Mol Cell Endocrinol, 179, 39, 10.1016/S0303-7207(01)00469-5
Jeppesen, 2012, LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles, J Clin Endocrinol Metab, 97, E1524, 10.1210/jc.2012-1427
Rodrigues, 2015, Direct actions of androgens on the survival, growth and secretion of steroids and anti-Müllerian hormone by individual macaque follicles during three-dimensional culture, Hum Reprod, 30, 664, 10.1093/humrep/deu335
Hoffman, 1965, [On the action of intraovarian injection of androgen on follicle and corpus luteum maturation in women], Geburtshilfe Frauenheilklinic, 25, 1132
Franks, 2008, Follicle dynamics and anovulation in polycystic ovary syndrome, Hum Reprod Update, 14, 367, 10.1093/humupd/dmn015
Willis, 1998, Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation, J Clin Endocrinol Metab, 83, 3984
Hillier, 1997, Role of androgens in follicle maturation and atresia, Baillieres Clin Obstet Gynaecol, 11, 249, 10.1016/S0950-3552(97)80036-3
Tingen, 2011, A macrophage and theca cell-enriched stromal cell population influences growth and survival of immature murine follicles in vitro, Reproduction, 141, 809, 10.1530/REP-10-0483
Woodruff, 2011, A new hypothesis regarding ovarian follicle development: ovarian rigidity as a regulator of selection and health, J Assist Reprod Genet, 28, 3, 10.1007/s10815-010-9478-4
Roberts, 2007, Neutralization of endogenous vascular endothelial growth factor depletes primordial follicles in the mouse ovary, Biol Reprod, 76, 218, 10.1095/biolreprod.106.050880
Nakamura, 2009, Adrenal changes associated with adrenarche, Rev Endocr Metab Disord, 10, 19, 10.1007/s11154-008-9092-2
Rosenfield, 1971, Plasma 17-ketosteroids and 17-β hydroxysteroids in girls with premature development of sexual hair, J Pediatr, 79, 260, 10.1016/S0022-3476(71)80111-7
Rich, 1981, Adrenarche: changing adrenal response to adrenocorticotropin, J Clin Endocrinol Metab, 52, 1129, 10.1210/jcem-52-6-1129
Rainey, 2002, Dissecting human adrenal androgen production, Trends Endocrinol Metab, 13, 234, 10.1016/S1043-2760(02)00609-4
Noordam, 2009, Inactivating PAPSS2 mutations in a patient with premature pubarche, N Engl J Med, 360, 2310, 10.1056/NEJMoa0810489
Baulieu, 1965, An adrenal-secreted “androgen”: dehydroisoandrosterone sulfate. Its metabolism and a tentative generalization on the metabolism of other steroid conjugates in man, Rec Prog Horm Res, 21, 411
Battista, 2009, 24-dehydrocholesterol reductase/seladin-1: a key protein differentially involved in adrenocorticotropin effects observed in human and rat adrenal cortex, Endocrinology, 150, 4180, 10.1210/en.2009-0410
Nakamura, 2009, Type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis, J Clin Endocrinol Metab, 94, 2192, 10.1210/jc.2008-2374
Mills, 1962, The relationship between the production of cortisol and androgen by the human adrenal, The Human Adrenal Cortex
Grumbach, 1978, Clinical disorders of adrenal function and puberty: an assessment of the role of the adrenal cortex in normal and abnormal puberty in man and evidence for an ACTH-like pituitary adrenal androgen stimulating hormone, The Endocrine Function of the Human Adrenal Cortex, 583
Biason-Lauber, 2000, Effect of leptin on CYP17 enzymatic activities in human adrenal cells: new insight in the onset of adrenarche, Endocrinology, 141, 1446, 10.1210/endo.141.4.7402
Guercio, 2003, Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls, J Clin Endocrinol Metab, 88, 1389, 10.1210/jc.2002-020979
Baquedano, 2005, Expression of the IGF system in human adrenal tissues from early infancy to late puberty: implications for the development of adrenarche, Pediatr Res, 58, 451, 10.1203/01.PDR.0000179392.59060.93
Smith, 1989, Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life, J Clin Endocrinol Metab, 68, 932, 10.1210/jcem-68-5-932
Palmert, 2001, The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process, J Clin Endocrinol Metab, 86, 4536, 10.1210/jcem.86.9.7863
Endoh, 1996, The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3β-hydroxysteroid dehydrogenase, J Clin Endocrinol Metab, 81, 3558
l'Allemand, 1996, Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells, J Clin Endocrinol Metab, 81, 3892
Taha, 2005, Absent or delayed adrenarche in Pit-1/POU1F1 deficiency, Horm Res, 64, 175
Ehrhart-Bornstein, 1998, Intraadrenal interactions in the regulation of adrenocortical steroidogenesis, Endocr Rev, 19, 101, 10.1210/edrv.19.2.0326
Rege, 2015, Bone morphogenetic protein-4 (BMP4): a paracrine regulator of human adrenal C19 steroid synthesis, Endocrinology, 156, 2530, 10.1210/en.2014-1942
Udhane, 2015, Retinoic acid receptor β and angiopoietin-like protein 1 are involved in the regulation of human androgen biosynthesis, Sci Rep, 5, 10132, 10.1038/srep10132
Rosenfield, 1972, Role of androgens in growth and development of the fetus, child, and adolescent, Adv Pediatr, 19, 171, 10.1016/S0065-3101(22)00562-X
Quinkler, 2004, Androgen generation in adipose tissue in women with simple obesity–a site-specific role for 17β-hydroxysteroid dehydrogenase type 5, J Endocrinol, 183, 331, 10.1677/joe.1.05762
Longcope, 1986, Androgen and estrogen metabolism: relationship to obesity, Metabolism, 35, 235, 10.1016/0026-0495(86)90206-4
Bélanger, 2002, Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity, Horm Metab Res, 34, 737, 10.1055/s-2002-38265
Kershaw, 2004, Adipose tissue as an endocrine organ, J Clin Endocrinol Metab, 89, 2548, 10.1210/jc.2004-0395
McTernan, 2000, Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue, Int J Obes Rel Metab Disord, 24, 875, 10.1038/sj.ijo.0801254
Subbaramaiah, 2011, Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland, Cancer Prev Res (Phila), 4, 329, 10.1158/1940-6207.CAPR-10-0381
Tsilchorozidou, 2003, Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5α-reduction but not the elevated adrenal steroid production rates, J Clin Endocrinol Metab, 88, 5907, 10.1210/jc.2003-030240
Mowszowicz, 1983, Dihydrotestosterone stimulates 5α-reductase activity in public skin fibroblasts, J Clin Endocrinol Metab, 53, 320, 10.1210/jcem-56-2-320
Rosenfield, 1983, The role of proteins in the distribution of plasma androgens and estradiol, Androgenization in Women, 25
Pugeat, 2010, Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome, Mol Cell Endocrinol, 316, 53, 10.1016/j.mce.2009.09.020
Nestler, 1991, A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome, J Clin Endocrinol Metab, 72, 83, 10.1210/jcem-72-1-83
Simó, 2012, Potential role of tumor necrosis factor-α in downregulating sex hormone-binding globulin, Diabetes, 61, 372, 10.2337/db11-0727
Hogeveen, 2002, Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction, J Clin Invest, 109, 973, 10.1172/JCI0214060
Mortensen, 2009, Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population, J Clin Endocrinol Metab, 94, 1579, 10.1210/jc.2008-2771
Rosenfield, 1994, Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism, J Clin Endocrinol Metab, 79, 1686
Ibañez, 1996, Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing, J Clin Endocrinol Metab, 81, 4103
Rosenfield, 1980, Pubertal presentation of congenital Δ5–3β-hydroxysteroid dehydrogenase deficiency, J Clin Endocrinol Metab, 51, 345, 10.1210/jcem-51-2-345
Barnes, 1994, Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women, J Clin Endocrinol Metab, 79, 1328
Derksen, 1994, Identification of virilizing adrenal tumors in hirsute women, N Engl J Med, 331, 968, 10.1056/NEJM199410133311502
Kaltsas, 2003, The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women, J Clin Endocrinol Metab, 88, 2634, 10.1210/jc.2002-020922
Azziz, 2004, Androgen excess in women: experience with over 1000 consecutive patients, J Clin Endocrinol Metab, 89, 453, 10.1210/jc.2003-031122
Carmina, 2006, Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism, J Clin Endocrinol Metab, 91, 2, 10.1210/jc.2005-1457
Rosenfield, 2015, Hyperandrogenism, hirsutism, and the polycystic ovary syndrome, Endocrinology, 7th ed, 2275
Gilling-Smith, 1997, Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome, Clin Endocrinol, 47, 93, 10.1046/j.1365-2265.1997.2321049.x
Pasquali, 2007, 17-Hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome, J Clin Endocrinol Metab, 92, 4208, 10.1210/jc.2007-0870
Maas, 2015, Relationship between 17-hydroxyprogesterone responses to human chorionic gonadotropin and markers of ovarian follicle morphology in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 100, 293, 10.1210/jc.2014-2956
Escobar-Morreale, 2005, The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery, J Clin Endocrinol Metab, 90, 6364, 10.1210/jc.2005-1490
Domecq, 2013, Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis, J Clin Endocrinol Metab, 98, 4655, 10.1210/jc.2013-2385
Polson, 1988, Polycystic ovaries–a common finding in normal women, Lancet, 331, 870, 10.1016/S0140-6736(88)91612-1
Farquhar, 1994, The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women, Aust N Z J Obstet Gynaecol, 34, 67, 10.1111/j.1479-828X.1994.tb01041.x
Chang, 2000, Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing, J Clin Endocrinol Metab, 85, 995
Johnstone, 2010, The polycystic ovary post-Rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance, J Clin Endocrinol Metab, 95, 4965, 10.1210/jc.2010-0202
Hart, 2010, Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS), Fertil Steril, 94, 1118, 10.1016/j.fertnstert.2009.11.002
Villarroel, 2011, Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone, Hum Reprod, 26, 2861, 10.1093/humrep/der223
Legro, 2005, Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype, J Clin Endocrinol Metab, 90, 2571, 10.1210/jc.2004-0219
Murphy, 2006, Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome, J Clin Endocrinol Metab, 91, 3878, 10.1210/jc.2006-1085
Sjaarda, 2014, Increased androgen, anti-Müllerian hormone, and sporadic anovulation in healthy, eumenorrheic women: a mild PCOS-like phenotype?, J Clin Endocrinol Metab, 99, 2208, 10.1210/jc.2013-3781
Depmann, 2015, The relationship between variation in size of the primordial follicle pool and age at natural menopause, J Clin Endocrinol Metab, 100, E845, 10.1210/jc.2015-1298
Unlu, 2016, Adrenal gland volume assessed by magnetic resonance imaging in women with polycystic ovary syndrome, Diagn Interv Imaging, 97, 57, 10.1016/j.diii.2015.02.004
Rotter, 1985, A genetic component to the variation of dehydroepiandrosterone sulfate, Metabolism, 34, 731, 10.1016/0026-0495(85)90023-X
Rice, 1993, The Cincinnati Myocardial Infarction and Hormone Family Study: family resemblance for dehydroepiandrosterone sulfate in control and myocardial infarction families, Metabolism, 42, 1284, 10.1016/0026-0495(93)90126-9
Louwers, 2013, Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype, J Clin Endocrinol Metab, 98, 3848, 10.1210/jc.2013-1976
Jain, 2007, Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women, J Clin Endocrinol Metab, 92, 2468, 10.1210/jc.2006-2274
Yeung, 2013, Adiposity and sex hormones across the menstrual cycle: the BioCycle Study, Int J Obes, 37, 237, 10.1038/ijo.2012.9
Roth, 2014, Luteal phase dynamics of follicle-stimulating and luteinizing hormones in obese and normal weight women, Clin Endocrinol, 81, 418, 10.1111/cen.12441
Al-Safi, 2015, Estradiol priming improves gonadotrope sensitivity and pro-inflammatory cytokines in obese women, J Clin Endocrinol Metab, 100, 4372, 10.1210/jc.2015-1946
Pache, 1991, Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome?, Histopathology, 19, 445, 10.1111/j.1365-2559.1991.tb00235.x
Rosenfield, 2001, Polycystic ovary syndrome and insulin-resistant hyperinsulinemia, J Am Acad Dermatol, 45, S095, 10.1067/mjd.2001.117430
Diamanti-Kandarakis, 2012, Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications, Endocr Rev, 33, 981, 10.1210/er.2011-1034
Lewy, 2001, Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome, J Pediatr, 138, 38, 10.1067/mpd.2001.109603
Poretsky, 2001, Phosphatidyl-inositol-3 kinase-independent insulin action pathway(s) in the human ovary, J Clin Endocrinol Metab, 86, 3115
Jakimiuk, 2001, Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries, J Clin Endocrinol Metab, 86, 1318
McAllister, 2015, Functional genomics of PCOS: from GWAS to molecular mechanisms, Trends Endocrinol Metab, 26, 118, 10.1016/j.tem.2014.12.004
Rosenfield, 2000, Diagnosis of polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism, J Pediatr Endocrinol Metab, 13, 1285
Azziz, 1998, Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis, J Clin Endocrinol Metab, 83, 2317
Goodarzi, 2015, DHEA, DHEAS and PCOS, J Ster Biochem Mol Biol, 145, 213, 10.1016/j.jsbmb.2014.06.003
Barnes, 1993, Ovarian steroidogenic responses to the gonadotropin-releasing hormone agonist nafarelin in hirsute women thought to have 3β-hydroxysteroid dehydrogenase deficiency, J Clin Endocrinol Metab, 76, 450
Lutfallah, 2002, Newly proposed hormonal criteria via genotypic proof for type II 3β-hydroxysteroid dehydrogenase deficiency, J Clin Endocrinol Metab, 87, 2611
Carbunaru, 2004, The hormonal phenotype of nonclassic 3 β-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency, J Clin Endocrinol Metab, 89, 783, 10.1210/jc.2003-030934
Gonzalez, 1996, Evidence for heterogeneous etiologies of adrenal dysfunction in polycystic ovary syndrome, Fertil Steril, 66, 354, 10.1016/S0015-0282(16)58500-8
Rosenfield, 1996, Evidence that idiopathic functional adrenal hyperandrogenism is caused by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may be involved, J Clin Endocrinol Metab, 81, 878
Arslanian, 2002, Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance, J Clin Endocrinol Metab, 87, 1555, 10.1210/jcem.87.4.8398
Mai, 2008, Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial, J Clin Endocrinol Metab, 93, 3900, 10.1210/jc.2008-0714
Bellanger, 2012, Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells, Steroids, 77, 347, 10.1016/j.steroids.2011.12.017
Ditkoff, 1995, The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome, J Clin Endocrinol Metab, 80, 603
Topor, 2011, Cortisol stimulates secretion of dehydroepiandrosterone in human adrenocortical cells through inhibition of 3βHSD2, J Clin Endocrinol Metab, 96, E31, 10.1210/jc.2010-0692
Vassiliadi, 2009, Increased 5 α-reductase activity and adrenocortical drive in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 94, 3558, 10.1210/jc.2009-0837
Gambineri, 2006, Genetic variation in 11β-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome, J Clin Endocrinol Metab, 91, 2295, 10.1210/jc.2005-2222
Michael, 2013, Ovarian 11β-hydroxysteroid dehydrogenase (11βHSD) activity is suppressed in women with anovulatory polycystic ovary syndrome (PCOS): apparent role for ovarian androgens, J Clin Endocrinol Metab, 98, 3375, 10.1210/jc.2013-1385
Zhu, 2010, Aberrantly increased mRNA expression of betaglycan, an inhibin co-receptor in the ovarian tissues in women with polycystic ovary syndrome, J Obstet Gynaecol Res, 36, 138, 10.1111/j.1447-0756.2009.01103.x
Gilling-Smith, 1994, Hypersecretion of androstenedione by isolated theca cells from polycystic ovaries, J Clin Endocrinol Metab, 79, 1158
Magarelli, 1996, Developmental and hormonal regulation of rat theca-cell differentiation factor secretion in ovarian follicles, Biol Reprod, 55, 416, 10.1095/biolreprod55.2.416
Liu, 2015, Lineage specification of ovarian theca cells requires multicellular interactions via oocyte and granulosa cells, Nat Commun, 6, 6934, 10.1038/ncomms7934
Hughesdon, 1982, Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called “hyperthecosis.”, Obstet Gynecol Surv, 37, 59, 10.1097/00006254-198202000-00001
Webber, 2003, Formation and early development of follicles in the polycystic ovary, Lancet, 362, 1017, 10.1016/S0140-6736(03)14410-8
Webber, 2007, Prolonged survival in culture of preantral follicles from polycystic ovaries, J Clin Endocrinol Metab, 92, 1975, 10.1210/jc.2006-1422
Wei, 2014, Reduced and delayed expression of GDF9 and BMP15 in ovarian tissues from women with polycystic ovary syndrome, J Assist Reprod Genet, 31, 1483, 10.1007/s10815-014-0319-8
Pellatt, 2007, Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries, J Clin Endocrinol Metab, 92, 240, 10.1210/jc.2006-1582
Alebić, 2015, The phenotypic diversity in per-follicle anti-Mullerian hormone production in polycystic ovary syndrome, Hum Reprod, 30, 1927, 10.1093/humrep/dev131
Mason, 1994, Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid, J Clin Endocrinol Metab, 79, 1355
Coffler, 2003, Evidence for abnormal granulosa cell responsiveness to follicle-stimulating hormone in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 88, 1742, 10.1210/jc.2002-021280
Zachos, 2003, Developmental regulation of follicle-stimulating hormone receptor messenger RNA expression in the baboon fetal ovary, Biol Reprod, 68, 1911, 10.1095/biolreprod.102.011494
Lofrano-Porto, 2007, Luteinizing hormone β mutation and hypogonadism in men and women, N Engl J Med, 357, 897, 10.1056/NEJMoa071999
Scheele, 1993, The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome, Hum Reprod, 8, 699, 10.1093/oxfordjournals.humrep.a138123
el-Roeiy, 1994, Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF- binding proteins-1–6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries, J Clin Endocrinol Metab, 78, 1488
Hendriks, 2007, Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome, Hum Reprod Update, 13, 249, 10.1093/humupd/dml058
Hu, 2004, [The differential expression profile of polycystic ovary syndrome associated genes], Beijing Da Xue Xue Bao, 36, 600
Kaur, 2012, Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis, J Clin Endocrinol Metab, 97, E2016, 10.1210/jc.2011-3441
Lan, 2015, Functional microarray analysis of differentially expressed genes in granulosa cells from women with polycystic ovary syndrome related to MAPK/ERK signaling, Sci Rep, 5, 14994, 10.1038/srep14994
Wood, 2007, Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis, J Clin Endocrinol Metab, 92, 705, 10.1210/jc.2006-2123
Ludwig, 2010, The association between pregnancy weight gain and birthweight: a within-family comparison, Lancet, 376, 984, 10.1016/S0140-6736(10)60751-9
Kdous, 2009, [Oocyte and embryo quality and outcome of ICSI cycles in patients with polycystic ovary syndrome (PCOS) versus normo-ovulatory], J Gynecol Obstet Biol Reprod (Paris), 38, 133, 10.1016/j.jgyn.2008.12.001
Grundy, 2004, Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition, Circulation, 109, 433, 10.1161/01.CIR.0000111245.75752.C6
Apridonidze, 2005, Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 90, 1929, 10.1210/jc.2004-1045
Coviello, 2006, Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance, J Clin Endocrinol Metab, 91, 492, 10.1210/jc.2005-1666
Leibel, 2006, Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome, J Clin Endocrinol Metab, 91, 1275, 10.1210/jc.2005-1707
Nandalike, 2011, Screening for sleep-disordered breathing and excessive daytime sleepiness in adolescent girls with polycystic ovarian syndrome, J Pediatr, 159, 591, 10.1016/j.jpeds.2011.04.027
Rossi, 2008, Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome, J Clin Endocrinol Metab, 93, 4780, 10.1210/jc.2008-1198
DeUgarte, 2005, Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment, Fertil Steril, 83, 1454, 10.1016/j.fertnstert.2004.11.070
Kahn, 2001, Clinical review 135: the importance of β-cell failure in the development and progression of type 2 diabetes, J Clin Endocrinol Metab, 86, 4047
Stepto, 2013, Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp, Hum Reprod, 28, 777, 10.1093/humrep/des463
Robinson, 1993, The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries, Clin Endocrinol, 39, 351, 10.1111/j.1365-2265.1993.tb02376.x
Legro, 2015, Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome, J Clin Endocrinol Metab, 100, 4048, 10.1210/jc.2015-2778
Turkmen, 2016, Roux-en-Y gastric bypass surgery in patients with polycystic ovary syndrome and metabolic syndrome, Obes Surg, 26, 111, 10.1007/s11695-015-1729-0
Ehrmann, 1995, Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus, J Clin Invest, 96, 520, 10.1172/JCI118064
Dunaif, 1996, β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome, J Clin Endocrinol Metab, 81, 942
Ehrmann, 1999, Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome, Diabetes Care, 22, 141, 10.2337/diacare.22.1.141
Colilla, 2001, Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives, J Clin Endocrinol Metaab, 86, 2027
Dunaif, 1992, Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome, Diabetes, 41, 1257, 10.2337/diab.41.10.1257
Corbould, 2005, Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling, Am J Physiol Endocrinol Metab, 288, E1047, 10.1152/ajpendo.00361.2004
Tosi, 2015, Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 100, 661, 10.1210/jc.2014-2786
Book, 1999, Selective insulin resistance in the polycystic ovary syndrome, J Clin Endocrinol Metab, 84, 3110
Nestler, 1998, Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system, J Clin Endocrinol Metab, 83, 2001
Willis, 1995, Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor, J Clin Endocrinol Metab, 80, 3788, 10.1210/jcem.80.12.8530637
DiVall, 2015, Insulin receptor signaling in the GnRH neuron plays a role in the abnormal GnRH pulsatility of obese female mice, PLoS One, 10, e0119995, 10.1371/journal.pone.0119995
Kristiansen, 1997, Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells, Steroids, 62, 258, 10.1016/S0039-128X(96)00223-1
Lungu, 2012, Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome, J Clin Endocrinol Metab, 97, 563, 10.1210/jc.2011-1896
Kaltsas, 2007, Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly, Clin Endocrinol, 67, 917, 10.1111/j.1365-2265.2007.02987.x
Flier, 1993, Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resisitance, J Clin Endocrinol Metab, 76, 1533
Conn, 2000, The prevalence of polycystic ovaries in women with type 2 diabetes mellitus, Clin Endocrinol, 52, 81, 10.1046/j.1365-2265.2000.00884.x
Peppard, 2001, Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes, Diabetes Care, 24, 1050, 10.2337/diacare.24.6.1050
Codner, 2007, Clinical review: hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus, J Clin Endocrinol Metab, 92, 1209, 10.1210/jc.2006-2641
Nestler, 1996, Decreases in ovarian cytochrome P450c17a activity and serum free testosterone after reduction of insulin secretion in women with polycystic ovary syndrome, N Engl J Med, 335, 617, 10.1056/NEJM199608293350902
Eid, 2005, Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass, Surg Obes Relat Dis, 1, 77, 10.1016/j.soard.2005.02.008
Moran, 2007, The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome, J Clin Endocrinol Metab, 92, 3796, 10.1210/jc.2007-1188
Harborne, 2003, Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome, Lancet, 361, 1894, 10.1016/S0140-6736(03)13493-9
Cosma, 2008, Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials, J Clin Endocrinol Metab, 93, 1135, 10.1210/jc.2007-2429
Tang, 2006, Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study, Hum Reprod, 21, 80, 10.1093/humrep/dei311
Tang, 2012, Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility, Cochrane Database Syst Rev, CD003053
Papaleo, 2007, Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction, Gynecol Endocrinol, 23, 700, 10.1080/09513590701672405
Facchinetti, 2015, Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS, Europ J Obstet Gynecol Reprod Biol, 195, 72, 10.1016/j.ejogrb.2015.09.024
Ibáñez, 2013, Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity, J Clin Endocrinol Metab, 98, E902, 10.1210/jc.2013-1041
Ibáñez, 2014, Hyperinsulinaemic androgen excess in adolescent girls, Nat Rev Endocrinol, 10, 499, 10.1038/nrendo.2014.58
Matthews, 1985, Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883
Ibanez, 1996, Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism, J Clin Endocrinol Metab, 81, 1237
Baillargeon, 2004, Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity, Fertil Steril, 82, 893, 10.1016/j.fertnstert.2004.02.127
Pau, 2014, Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study, J Clin Endocrinol Metab, 99, 1870, 10.1210/jc.2013-4021
Miller, 2013, Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP, Nature, 494, 256, 10.1038/nature11808
Pernicova, 2014, Metformin–mode of action and clinical implications for diabetes and cancer, Nat Rev Endocrinol, 10, 143, 10.1038/nrendo.2013.256
Madiraju, 2014, Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase, Nature, 510, 542, 10.1038/nature13270
Buse, 2015, The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies, Diabetes Care, 39, 198, 10.2337/dc15-0488
Legro, 2008, Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene, J Clin Endocrinol Metab, 93, 792, 10.1210/jc.2007-1736
Kurzthaler, 2014, Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects, Reprod Biol Endocrinol, 12, 98, 10.1186/1477-7827-12-98
Di Pietro, 2015, Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model, Endocrinology, 156, 1453, 10.1210/en.2014-1765
Rice, 2013, Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome, J Clin Endocrinol Metab, 98, E1491, 10.1210/jc.2013-1865
Jensterle, 2015, A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome, Hormones, 14, 81, 10.1007/BF03401383
Jensterle Sever, 2014, Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin, Eur J Endocrinol, 170, 451, 10.1530/EJE-13-0797
Outeiriño-Iglesias, 2015, GLP-1 increases preovulatory LH source and the number of mature follicles, as well as synchronizing the onset of puberty in female rats, Endocrinology, 156, 4226, 10.1210/en.2014-1978
Kahn, 2003, Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes, Exp Diabesity Res, 4, 169, 10.1155/EDR.2003.169
Ciaraldi, 1992, Cellular mechanisms of insulin resistance in polycystic ovarian syndrome, J Clin Endocrinol Metab, 75, 577
Ciaraldi, 1997, Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity, J Clin Endocrinol Metab, 82, 1421
Marsden, 1994, Severe impairment of insulin action in adipocytes from amenorrheic subjects with polycystic ovary syndrome, Metabolism, 43, 1536, 10.1016/0026-0495(94)90013-2
Rosenbaum, 1993, Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes, Am J Physiol, 264, E197
Chen, 2013, miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance, Diabetes, 62, 2278, 10.2337/db12-0963
Corbould, 2007, The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome, Metabolism, 56, 716, 10.1016/j.metabol.2006.12.021
Corbould, 2007, Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women, J Endocrinol, 192, 585, 10.1677/joe.1.07070
Corbould, 2008, Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?, Diabetes Metab Res Rev, 24, 520, 10.1002/dmrr.872
Varlamov, 2012, Androgen effects on adipose tissue architecture and function in nonhuman primates, Endocrinology, 153, 3100, 10.1210/en.2011-2111
Capllonch-Amer, 2014, Opposite effects of 17-β estradiol and testosterone on mitochondrial biogenesis and adiponectin synthesis in white adipocytes, J Mol Endocrinol, 52, 203, 10.1530/JME-13-0201
Huang, 2013, PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity, J Clin Endocrinol Metab, 98, E17, 10.1210/jc.2012-2697
Li, 2014, Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis, Tumour Biol, 35, 3961, 10.1007/s13277-013-1595-0
Chazenbalk, 2013, Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation, Steroids, 78, 920, 10.1016/j.steroids.2013.05.001
Keller, 2014, Impaired preadipocyte differentiation into adipocytes in subcutaneous abdominal adipose of PCOS-like female rhesus monkeys, Endocrinology, 155, 2696, 10.1210/en.2014-1050
Polderman, 1994, Induction of insulin resistance by androgens and estrogens, J Clin Endocrinol Metab, 79, 265
Varlamov, 2013, Ovarian cycle-specific regulation of adipose tissue lipid storage by testosterone in female nonhuman primates, Endocrinology, 154, 4126, 10.1210/en.2013-1428
Upreti, 2014, 5α-reductase type 1 modulates insulin sensitivity in men, J Clin Endocrinol Metab, 99, E1397, 10.1210/jc.2014-1395
Livingstone, 2015, 5α-Reductase type 1 deficiency or inhibition predisposes to insulin resistance, hepatic steatosis, and liver fibrosis in rodents, Diabetes, 64, 447, 10.2337/db14-0249
Lee, 2014, Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity, Biochim Biophys Acta, 1842, 473, 10.1016/j.bbadis.2013.05.029
Morgan, 2014, 11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess, Proc Natl Acad Sci USA, 111, E2482, 10.1073/pnas.1323681111
Ehrmann, 2004, Impaired β-cell compensation to dexamethasone-induced hyperglycemia in women with polycystic ovary syndrome, Am J Physiol Endocrinol Metab, 287, E241, 10.1152/ajpendo.00475.2003
Chapman, 2013, 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action, Physiol Rev, 93, 1139, 10.1152/physrev.00020.2012
Desarzens, 2016, Adipocyte glucocorticoid receptor has a minor contribution in adipose tissue growth, J Endocrinol, 230, 1, 10.1530/JOE-16-0121
Carmina, 1992, Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?, Am J Obstet Gynecol, 167, 1807, 10.1016/0002-9378(92)91779-A
Ezeh, 2013, Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome, J Clin Endocrinol Metab, 98, E1088, 10.1210/jc.2013-1295
Kirchengast, 2001, Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome, Hum Reprod, 16, 1255, 10.1093/humrep/16.6.1255
Barber, 2008, Global adiposity rather than abnormal regional fat distribution characterises women with polycystic ovary syndrome, J Clin Endocrinol Metab, 93, 999, 10.1210/jc.2007-2117
Mannerås-Holm, 2011, Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance, J Clin Endocrinol Metab, 96, E304, 10.1210/jc.2010-1290
Borruel, 2013, Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS), J Clin Endocrinol Metab, 98, 1254, 10.1210/jc.2012-3698
Arner, 2005, Effects of testosterone on fat cell lipolysis. Species differences and possible role in polycystic ovarian syndrome, Biochimie, 87, 39, 10.1016/j.biochi.2004.11.012
Ek, 2002, A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance, Diabetes, 51, 484, 10.2337/diabetes.51.2.484
Faulds, 2003, Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome, J Clin Endocrinol Metab, 88, 2269, 10.1210/jc.2002-021573
Dicker, 2004, Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots, Diabetologia, 47, 420, 10.1007/s00125-003-1324-0
Samuel, 2010, Lipid-induced insulin resistance: unravelling the mechanism, Lancet, 375, 2267, 10.1016/S0140-6736(10)60408-4
Chen, 2015, Phenotypic characterization of insulin-resistant and insulin-sensitive obesity, J Clin Endocrinol Metab, 100, 4082, 10.1210/jc.2015-2712
Varlamov, 2016, Hyperandrogenemia induces adipose tissue dysfunction in adolescent female rhesus macaques consuming a western-style diet, Endocr Rev, 37
González, 2014, The altered mononuclear cell-derived cytokine response to glucose ingestion is not regulated by excess adiposity in polycystic ovary syndrome, J Clin Endocrinol Metab, 99, E2244, 10.1210/jc.2014-2046
Shorakae, 2015, The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome, Semin Reprod Med, 33, 257, 10.1055/s-0035-1556568
González, 2014, Hyperandrogenism induces a proinflammatory TNFα response to glucose ingestion in a receptor-dependent fashion, J Clin Endocrinol Metab, 99, E848, 10.1210/jc.2013-4109
Tasali, 2006, Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome, J Clin Endocrinol Metab, 91, 36, 10.1210/jc.2005-1084
Tasali, 2011, Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome, J Clin Endocrinol Metab, 96, 365, 10.1210/jc.2010-1187
Vgontzas, 2001, Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance, J Clin Endocrinol Metab, 86, 517
Broussard, 2012, Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study, Ann Intern Med, 157, 549, 10.7326/0003-4819-157-8-201210160-00005
Ehrmann, 2012, Metabolic dysfunction in PCOS: relationship to obstructive sleep apnea, Steroids, 77, 290, 10.1016/j.steroids.2011.12.001
Narkiewicz, 1998, Altered cardiovascular variability in obstructive sleep apnea, Circulation, 98, 1071, 10.1161/01.CIR.98.11.1071
Sverrisdóttir, 2008, Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?, Am J Physiol Endocrinol Metab, 294, E576, 10.1152/ajpendo.00725.2007
Lambert, 2015, Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance, Clin Endocrinol, 83, 812, 10.1111/cen.12803
Holte, 1994, The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women, Clin Endocrinol, 41, 473, 10.1111/j.1365-2265.1994.tb02578.x
Taylor, 1997, Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome, J Clin Endocrinol Metab, 82, 2248
Arroyo, 1997, Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity, J Clin Endocrinol Metab, 82, 3728
Rochester, 2009, Partial recovery of luteal function after bariatric surgery in obese women, Fertil Steril, 92, 1410, 10.1016/j.fertnstert.2008.08.025
Pagán, 2006, Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions, J Clin Endocrinol Metab, 91, 1309, 10.1210/jc.2005-2099
Srouji, 2007, Pharmacokinetic factors contribute to the inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome, J Clin Endocrinol Metab, 92, 1347, 10.1210/jc.2006-2716
Wide, 2009, Serum half-life of pituitary gonadotropins is decreased by sulfonation and increased by sialylation in women, J Clin Endocrinol Metab, 94, 958, 10.1210/jc.2008-2070
Wide, 2007, Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men, J Clin Endocrinol Metab, 92, 4410, 10.1210/jc.2007-1342
Mi, 2008, Ablation of GalNAc-4-sulfotransferase-1 enhances reproduction by altering the carbohydrate structures of luteinizing hormone in mice, J Clin Invest, 118, 1815
Eagleson, 2003, Obese patients with polycystic ovary syndrome: evidence that metformin does not restore sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by ovarian steroids, J Clin Endocrinol Metab, 88, 5158, 10.1210/jc.2003-030167
Lawson, 2008, Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women, J Clin Endocrinol Metab, 93, 2089, 10.1210/jc.2007-2656
Mehta, 2005, Luteinizing hormone secretion is not influenced by insulin infusion in women with polycystic ovary syndrome despite improved insulin sensitivity during pioglitazone treatment, J Clin Endocrinol Metab, 90, 2136, 10.1210/jc.2004-1040
Zumoff, 2003, Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone, Metabolism, 52, 1126, 10.1016/S0026-0495(03)00186-0
Lucky, 1979, Reduction of the potency of luteinizing hormone by estrogen, N Engl J Med, 300, 1034, 10.1056/NEJM197905033001808
Taponen, 2003, Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study, J Clin Endocrinol Metab, 88, 141, 10.1210/jc.2002-020982
Strain, 2003, Sex difference in the effect of obesity on 24-hour mean serum gonadotropin levels, Horm Metab Res, 35, 362, 10.1055/s-2003-41358
Teede, 2011, Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline, Med J Austral, 195, S65, 10.5694/mja11.10915
Jamal, 2012, Roux-en-Y gastric bypass ameliorates polycystic ovary syndrome and dramatically improves conception rates: a 9-year analysis, Surg Obes Relat Dis, 8, 440, 10.1016/j.soard.2011.09.022
O'Reilly, 2014, Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione, J Clin Endocrinol Metab, 99, 1027, 10.1210/jc.2013-3399
McCartney, 2002, Hypothalamic regulation of cyclic ovulation: evidence that the increase in gonadotropin-releasing hormone pulse frequency during the follicular phase reflects the gradual loss of the restraining effects of progesterone, J Clin Endocrinol Metab, 87, 2194, 10.1210/jcem.87.5.8484
Pastor, 1998, Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone, J Clin Endocrinol Metab, 83, 582
Eagleson, 2000, Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone, J Clin Endocrinol Metab, 85, 4047
Ropelato, 2009, Acute effects of testosterone infusion on the serum luteinizing hormone profile in eumenorrheic and polycystic ovary syndrome adolescents, J Clin Endocrinol Metab, 94, 3602, 10.1210/jc.2009-0402
Cimino, 2016, Novel role for anti-Mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion, Nat Commun, 7, 10055, 10.1038/ncomms10055
Zimmer, 2010, Potential diagnostic utility of intermittent administration of short-acting GnRH agonist administration in gonadotropin deficiency, Fertil Steril, 94, 2697, 10.1016/j.fertnstert.2010.04.019
Rege, 2013, Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation, J Clin Endocrinol Metab, 98, 1182, 10.1210/jc.2012-2912
Campana, 2016, Development of a novel cell based androgen screening model, J Ster Biochem Mol Biol, 156, 17, 10.1016/j.jsbmb.2015.11.005
Marti, 2016, The backdoor androgen biosynthesis pathway exists in the human ovary and seems altered in PCOS, Endocr Rev, 37
Rosenfield, 1971, Androgens and androgen responsiveness in the feminizing testis syndrome. Comparison of complete and “incomplete” forms, J Clin Endocrinol Metab, 32, 625, 10.1210/jcem-32-5-625
Kayampilly, 2010, Stimulatory effect of insulin on 5α-reductase type 1 (SRD5A1) expression through an Akt-dependent pathway in ovarian granulosa cells, Endocrinology, 151, 5030, 10.1210/en.2010-0444
Goodarzi, 2006, Variants in the 5α-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women, J Clin Endocrinol Metab, 91, 4085, 10.1210/jc.2006-0227
Hedstrom, 2015, Women with polycystic ovary syndrome have elevated serum concentrations of and altered GABA(A) receptor sensitivity to allopregnanolone, Clin Endocrinol, 83, 643, 10.1111/cen.12809
Wang, 2015, Alternative splicing of the androgen receptor in polycystic ovary syndrome, Proc Natl Acad Sci USA, 112, 4743, 10.1073/pnas.1418216112
Walters, 2016, Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?, Asian J Androl, 18, 442, 10.4103/1008-682X.161600
Escobar-Morreale, 2005, The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome, Endocr Rev, 26, 251, 10.1210/er.2004-0004
Zhang, 2013, Association of the CAG repeat polymorphisms in androgen receptor gene with polycystic ovary syndrome: a systemic review and meta-analysis, Gene, 524, 161, 10.1016/j.gene.2013.04.040
Vink, 2006, Heritability of polycystic ovary syndrome in a Dutch twin-family study, J Clin Endocrinol Metab, 91, 2100, 10.1210/jc.2005-1494
Legro, 1998, Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome, Proc Natl Acad Sci USA, 95, 14956, 10.1073/pnas.95.25.14956
Franks, 2008, Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries, J Clin Endocrinol Metab, 93, 3396, 10.1210/jc.2008-0369
Govind, 1999, Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families, J Clin Endocrinol Metab, 84, 38, 10.1210/jcem.84.1.5382
Kahsar-Miller, 2001, Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS, Fertil Steril, 75, 53, 10.1016/S0015-0282(00)01662-9
Sam, 2006, Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome, Proc Natl Acad Sci USA, 103, 7030, 10.1073/pnas.0602025103
Sam, 2005, Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome, J Clin Endocrinol Metab, 90, 4797, 10.1210/jc.2004-2217
Coviello, 2009, High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity, J Clin Endocrinol Metab, 94, 4361, 10.1210/jc.2009-1333
Louwers, 2013, Cross-ethnic meta-analysis of genetic variants for polycystic ovary syndrome, J Clin Endocrinol Metab, 98, E2006, 10.1210/jc.2013-2495
Williamson, 2001, The impact of ethnicity on the presentation of polycystic ovarian syndrome, Aust N Z J Obstet Gynaecol, 41, 202, 10.1111/j.1479-828X.2001.tb01210.x
Glintborg, 2010, Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark, Clin Endocrinol, 73, 732, 10.1111/j.1365-2265.2010.03873.x
Givens, 1988, Familial polycystic ovarian disease, Endocrinol Metab Clin N Am, 17, 771, 10.1016/S0889-8529(18)30409-2
Rosenfield, 2007, Identifying children at risk of polycystic ovary syndrome, J Clin Endocrinol Metab, 92, 787, 10.1210/jc.2006-2012
Sir-Petermann, 2009, Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome, J Clin Endocrinol Metab, 94, 1923, 10.1210/jc.2008-2836
Maliqueo, 2009, Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome, J Clin Endocrinol Metab, 94, 3282, 10.1210/jc.2009-0427
Sir-Petermann, 2006, Increased anti-mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome, J Clin Endocrinol Metab, 91, 3105, 10.1210/jc.2005-2693
Vanky, 2012, Androgens and antimullerian hormone in mothers with polycystic ovary syndrome and their newborns, Fertil Steril, 97, 509, 10.1016/j.fertnstert.2011.11.021
Kent, 2008, Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study, J Clin Endocrinol Metab, 93, 1662, 10.1210/jc.2007-1958
Carey, 1993, Evidence for a single gene effect causing polycystic ovaries and male pattern baldness, Clin Endocrinol, 38, 653, 10.1111/j.1365-2265.1993.tb02150.x
Wang, 2008, The complex relationship between hypothalamic amenorrhea and polycystic ovary syndrome, J Clin Endocrinol Metab, 93, 1394, 10.1210/jc.2007-1716
Robin, 2012, Polycystic ovary-like abnormalities (PCO-L) in women with functional hypothalamic amenorrhea, J Clin Endocrinol Metab, 97, 4236, 10.1210/jc.2012-1836
Povel, 2011, Shared genetic variance between the features of the metabolic syndrome: heritability studies, Mol Genet Metab, 104, 666, 10.1016/j.ymgme.2011.08.035
Yildiz, 2003, Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome, J Clin Endocrinol Metab, 88, 2031, 10.1210/jc.2002-021499
Kobaly, 2014, Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome, J Clin Endocrinol Metab, 99, 2961, 10.1210/jc.2013-4338
Urbanek, 1999, Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin, Proc Natl Acad Sci USA, 96, 8573, 10.1073/pnas.96.15.8573
Goodarzi, 2011, Polycystic ovary syndrome: etiology, pathogenesis and diagnosis, Nat Rev Endocrinol, 7, 219, 10.1038/nrendo.2010.217
Urbanek, 2007, The genetics of the polycystic ovary syndrome, Nat Clin Pract Endocrinol Metab, 3, 103, 10.1038/ncpendmet0400
Witchel, 1997, Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency, Biochem Mol Med, 62, 151, 10.1006/bmme.1997.2632
Ewens, 2010, Family-based analysis of candidate genes for polycystic ovary syndrome, J Clin Endocrinol Metab, 95, 2306, 10.1210/jc.2009-2703
Jones, 2012, Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility, J Clin Endocrinol Metab, 97, E1750, 10.1210/jc.2011-2153
Boqun, 2013, Expression of SET protein in the ovaries of patients with polycystic ovary syndrome, Int J Endocrinol, 2013, 367956, 10.1155/2013/367956
Piltonen, 2013, Mesenchymal stem/progenitors and other endometrial Cell types From women With polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential, J Clin Endocrinol Metab, 98, 3765, 10.1210/jc.2013-1923
Li, 2014, A possible new mechanism in the pathophysiology of polycystic ovary syndrome (PCOS): the discovery that leukocyte telomere length is strongly associated with PCOS, J Clin Endocrinol Metab, 99, E234, 10.1210/jc.2013-3685
Shi, 2012, Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome, Nat Genet, 44, 1020, 10.1038/ng.2384
Kosova, 2013, Genetics of the polycystic ovary syndrome, Mol Cell Endocrinol, 373, 29, 10.1016/j.mce.2012.10.009
Brower, 2015, Further investigation in Europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals, J Clin Endocrinol Metab, 100, E182, 10.1210/jc.2014-2689
Ha, 2015, Association study between polycystic ovarian syndrome and the susceptibility genes polymorphisms in Hui Chinese women, PLoS One, 10, e0126505, 10.1371/journal.pone.0126505
Hayes, 2015, A genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations, Nat Commun, 6, 7502, 10.1038/ncomms8502
Welt, 2012, Variants in DENND1A are associated with polycystic ovary syndrome in women of european ancestry, J Clin Endocrinol Metab, 97, E1342, 10.1210/jc.2011-3478
Yu, 2015, Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome, Fertil Steril, 104, 145, 10.1016/j.fertnstert.2015.04.005
Corbett, 2013, The polycystic ovary syndrome and recent human evolution, Mol Cell Endocrinol, 373, 39, 10.1016/j.mce.2013.01.001
Padmanabhan, 2011, Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming, Semin Reprod Med, 29, 173, 10.1055/s-0031-1275519
Dumesic, 2014, Intrauterine environment and polycystic ovary syndrome, Semin Reprod Med, 32, 159, 10.1055/s-0034-1371087
Ghizzoni, 1996, Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab, 81, 601
Abbott, 2013, Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood, Fertil Steril, 100, 2, 10.1016/j.fertnstert.2013.05.023
Nicol, 2014, Abnormal infant islet morphology precedes insulin resistance in PCOS-Like monkeys, PLoS One, 9, e106527, 10.1371/journal.pone.0106527
Veiga-Lopez, 2012, Developmental programming: prenatal testosterone excess disrupts anti-Mullerian hormone expression in preantral and antral follicles, Fertil Steril, 97, 748, 10.1016/j.fertnstert.2011.12.028
Caldwell, 2015, Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization, Endocrinology, 156, 1441, 10.1210/en.2014-1887
Nada, 2010, Developmental programming: differential effects of prenatal testosterone excess on insulin target tissues, Endocrinology, 151, 5165, 10.1210/en.2010-0666
Payne, 1974, Androgen formation from pregnenolone sulfate by the human fetal ovary, J Clin Endocrinol Metab, 39, 300, 10.1210/jcem-39-2-300
George, 1978, Conversion of androgen to estrogen by the human fetal ovary, J Clin Endocrinol Metab, 47, 550, 10.1210/jcem-47-3-550
Rabinovici, 1990, Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads, Endocr Rev, 11, 532, 10.1210/edrv-11-4-532
Cole, 2006, Human fetal ovary development involves the spatiotemporal expression of p450c17 protein, J Clin Endocrinol Metab, 91, 3654, 10.1210/jc.2006-0641
Fowler, 2011, Development of steroid signaling pathways during primordial follicle formation in the human fetal ovary, J Clin Endocrinol Metab, 96, 1754, 10.1210/jc.2010-2618
Peters, 1978, Follicular growth in fetal and prepubertal ovaries of humans and other primates, Clin Endocrinol Metab, 7, 469, 10.1016/S0300-595X(78)80005-X
Kuiri-Hänninen, 2011, Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls, J Clin Endocrinol Metab, 96, 3432, 10.1210/jc.2011-1502
Kuiri-Hänninen, 2013, Postnatal ovarian activation has effects in estrogen target tissues in infant girls, J Clin Endocrinol Metab, 98, 4709, 10.1210/jc.2013-1677
Ellinwood, 1983, Estradiol synthesis by fetal monkey ovaries correlates with antral follicle formation, Biol Reprod, 28, 505, 10.1095/biolreprod28.2.505
Wilson, 1979, The effect of trophic agents on fetal ovarian steroidogenesis in organ culture, Fertil Steril, 32, 73, 10.1016/S0015-0282(16)44119-1
Reyes, 1974, Studies on human sexual development. II. Fetal and maternal serum gonadotropin and sex steroid concentrations, J Clin Endocrinol Metab, 612, 10.1210/jcem-38-4-612
Beck-Peccoz, 1991, Maturation of hypothalamic-pituitary-gonadal function in normal human fetuses: circulating levels of gonadotropins, their common α-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone, J Clin Endocrinol Metab, 73, 525, 10.1210/jcem-73-3-525
Eberlein, 1965, Steroids and sterols in umbilical cord blood, J Clin Endocrinol Metab, 25, 1101, 10.1210/jcem-25-8-1101
Wudy, 1995, 17 α-hydroxyprogesterone, 4-androstenedione, and testosterone profiled by routine stable isotope dilution/gas chromatography-mass spectrometry in plasma of children, Pediatr Res, 38, 76, 10.1203/00006450-199507000-00013
Forest, 1980, Concentration of 14 steroid hormones in human amniotic fluid of midpregnancy, J Clin Endocrinol Metab, 51, 816, 10.1210/jcem-51-4-816
Ventura, 2013, Digit ratio (2D:4D) in newborns: influences of prenatal testosterone and maternal environment, Early Hum Dev, 89, 107, 10.1016/j.earlhumdev.2012.08.009
Fahlbusch, 2015, Measurement of amniotic fluid steroids of midgestation via LC-MS/MS, J Ster Biochem Mol Biol, 152, 155, 10.1016/j.jsbmb.2015.05.014
Caanen, 2016, Mass spectrometry methods measured androgen and estrogen concentrations during pregnancy and in newborns of mothers with polycystic ovary syndrome, Eur J Endocrinol, 174, 25, 10.1530/EJE-15-0699
Anderson, 2010, Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels, J Clin Endocrinol Metab, 95, 2180, 10.1210/jc.2009-2651
Hickey, 2009, The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study, J Clin Endocrinol Metab, 94, 3714, 10.1210/jc.2009-0544
Maliqueo, 2013, Placental steroidogenesis in pregnant women with polycystic ovary syndrome, Eur J Obstet Gynecol Reprod Biol, 166, 151, 10.1016/j.ejogrb.2012.10.015
Koster, 2015, Placental characteristics in women with polycystic ovary syndrome, Hum Reprod, 30, 2829
Palomba, 2012, Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study, Clin Endocrinol, 77, 898, 10.1111/j.1365-2265.2012.04443.x
Wilson, 2001, Androgens, androgen receptors, and male gender role behavior, Horm Behav, 40, 358, 10.1006/hbeh.2001.1684
Lee, 2006, Consensus statement on management of intersex disorders. International Consensus Conference on Intersex, Pediatrics, 118, e488, 10.1542/peds.2006-0738
Brunner, 2016, Gender role, gender identity and sexual orientation in CAIS (“XY-women”) compared with subfertile and infertile 46,XX women, J Sex Res, 53, 109, 10.1080/00224499.2014.1002124
Abbott, 2012, Early-to-mid gestation fetal testosterone increases right hand 2D:4D finger length ratio in polycystic ovary syndrome-like monkeys, PLoS One, 7, e42372, 10.1371/journal.pone.0042372
Torchen, 2016, Evidence for increased 5α-reductase activity during early childhood in daughters of women with polycystic ovary syndrome, J Clin Endocrinol Metab, 101, 2069, 10.1210/jc.2015-3926
Barker, 2002, Fetal origins of adult disease: strength of effects and biological basis, Int J Epidemiol, 31, 1235, 10.1093/ije/31.6.1235
Heijmans, 2008, Persistent epigenetic differences associated with prenatal exposure to famine in humans, Proc Natl Acad Sci USA, 105, 17046, 10.1073/pnas.0806560105
Ibáñez, 1998, Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism: relation to reduced fetal growth, J Clin Endocrinol Metab, 83, 3558, 10.1210/jcem.83.10.5205
Pandolfi, 2008, Low birth weight and later development of insulin resistance and biochemical/clinical features of polycystic ovary syndrome, Metabolism, 57, 999, 10.1016/j.metabol.2008.02.018
Melo, 2010, High prevalence of polycystic ovary syndrome in women born small for gestational age, Hum Reprod, 25, 2124, 10.1093/humrep/deq162
Davies, 2012, Birthweight and thinness at birth independently predict symptoms of polycystic ovary syndrome in adulthood, Hum Reprod, 27, 1475, 10.1093/humrep/des027
Cresswell, 1997, Fetal growth, length of gestation, and polycystic ovaries in adult life, Lancet, 350, 1131, 10.1016/S0140-6736(97)06062-5
Michelmore, 2001, Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight, Clin Endocrinol, 55, 439, 10.1046/j.1365-2265.2001.01375.x
Sadrzadeh, 2003, Birth weight and age at menarche in patients with polycystic ovary syndrome or diminished ovarian reserve, in a retrospective cohort, Hum Reprod, 18, 2225, 10.1093/humrep/deg409
Laitinen, 2003, Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms, Int J Obes, 27, 710, 10.1038/sj.ijo.0802301
Legro, 2010, Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives, J Clin Endocrinol Metab, 95, 789, 10.1210/jc.2009-1849
Fulghesu, 2015, Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome, Fertil Steril, 103, 808, 10.1016/j.fertnstert.2014.12.109
Franks, 2006, Controversy in Clin Endocrinol: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria, J Clin Endocrinol Metab, 91, 786, 10.1210/jc.2005-2501
Ehrmann, 1997, Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 82, 2108
Nestler, 1998, Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome, N Engl J Med, 338, 1876, 10.1056/NEJM199806253382603
Lord, 2003, Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome, Cochrane Database Syst Rev, CD003053
James, 2008, WHO recognition of the global obesity epidemic, Int J Obes (Lond), 32, S120, 10.1038/ijo.2008.247
Pasquali, 1989, Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss, J Clin Endocrinol Metab, 68, 173, 10.1210/jcem-68-1-173
Huber-Buchholz, 1999, Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone, J Clin Endocrinol Metab, 84, 1470
Kiddy, 1992, Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome, Clin Endocrinol, 36, 105, 10.1111/j.1365-2265.1992.tb02909.x
Bloch, 1987, Puberty decreases insulin sensitivity, J Pediatr, 110, 481, 10.1016/S0022-3476(87)80522-X
Caprio, 1994, Developmental changes in insulin action and secretion in childhood health and disease, Adv Endocrinol Metab, 5, 171
Caprio, 1999, Insulin: the other anabolic hormone of puberty, Acta Paediatr Suppl, 88, 84, 10.1111/j.1651-2227.1999.tb14410.x
Moran, 1999, Insulin resistance during puberty: results from clamp studies in 357 children, Diabetes, 48, 2039, 10.2337/diabetes.48.10.2039
van Houten, 2012, Reproductive and metabolic phenotype of a mouse model of PCOS, Endocrinology, 153, 2861, 10.1210/en.2011-1754
Nobels, 1992, Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis, Fertil Steril, 58, 655, 10.1016/S0015-0282(16)55307-2
Carel, 2009, Consensus statement on the use of gonadotropin-releasing hormone analogs in children, Pediatrics, 123, e752, 10.1542/peds.2008-1783
Chiavaroli, 2010, GNRH analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome, Eur J Endocrinol, 163, 55, 10.1530/EJE-09-1102
Ibañez, 1993, Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism, J Clin Endocrinol Metab, 76, 1599
Nelson-DeGrave, 2004, Valproate potentiates androgen biosynthesis in human ovarian theca cells, Endocrinology, 145, 799, 10.1210/en.2003-0940
Herzog, 2006, Menstrual disorders in women with epilepsy, Neurology, 66, S23, 10.1212/WNL.66.66_suppl_3.S23
Kandaraki, 2011, Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS, J Clin Endocrinol Metab, 96, E480, 10.1210/jc.2010-1658
Yang, 2015, Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study, Hum Reprod, 30, 1964, 10.1093/humrep/dev123
Azziz, 2011, Polycystic ovary syndrome: an ancient disorder?, Fertil Steril, 95, 1544, 10.1016/j.fertnstert.2010.09.032